Best supportive care and prognosis: advanced gastroesophageal adenocarcinoma.
Kirsty E CavanaghMark A BaxterRussell D PettyPublished in: BMJ supportive & palliative care (2021)
To our knowledge, this is the largest reported study in Europe of outcomes in patients with advanced GOA treated with BSC only. The mOS with BSC is approximately 3 months. Cancer stage and ECOG PS have a role in prognostication at diagnosis. Our findings support the benefit of palliative chemotherapy in this population, and real-world survival corresponds to published trial data.
Keyphrases
- healthcare
- palliative care
- locally advanced
- papillary thyroid
- squamous cell carcinoma
- study protocol
- clinical trial
- electronic health record
- randomized controlled trial
- quantum dots
- phase iii
- big data
- quality improvement
- room temperature
- free survival
- systematic review
- radiation therapy
- insulin resistance
- advanced cancer
- highly efficient
- weight loss
- newly diagnosed
- gold nanoparticles
- skeletal muscle
- data analysis
- artificial intelligence
- glycemic control